REVIEW article
Front. Endocrinol.
Sec. Reproduction
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1505213
This article is part of the Research TopicMale Reproduction and Oxidative Stress, Volume IIView all 15 articles
Deciphering the Role of Reactive Oxygen Species in Idiopathic Asthenozoospermia
Provisionally accepted- 1Department of Andrology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
- 2Department of Radiation Therapy, Dongguan Hospital of Guangzhou University of Chinese Medicine (Dongguan Traditional Chinese Medicine Hospital), Dongguan, 523000, China, Dongguan, China
- 3Anesthesia and surgery center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, China, Shenzhen, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Asthenozoospermia is a severe condition characterized by abnormal sperm motility, contributing to 50% of male infertility cases. Idiopathic asthenozoospermia refers to a form of this condition with no identifiable causes through routine clinical examinations, potentially linked to apoptosis and oxidative stress induced by excessive reactive oxygen species (ROS). At low concentrations, ROS positively influence physiological processes, including sperm mature and motility. However, elevated ROS levels can harm human spermatozoa through oxidative stress, primarily due to the absence of effective DNA damage repair mechanisms and inadequate antioxidant defenses. In this review, we summarize the physiological and pathophysiological roles, endogenous and exogenous sources, and therapeutic strategies related to ROS in idiopathic asthenozoospermia. Ultimately, maintaining a proper balance between ROS concentrations and antioxidants is crucial for ensuring male reproductive health.
Keywords: Reactive Oxygen Species, Idiopathic asthenozoospermia, Oxidative Stress, Sperm Motility, Antioxidants, male infertility
Received: 02 Oct 2024; Accepted: 25 Apr 2025.
Copyright: © 2025 Wang, Li, Zhou, Xu, Wang, Tan, Li, Li, Song and Yuan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Zilong Wang, Department of Andrology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
Xiaoli Li, Anesthesia and surgery center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, China, Shenzhen, China
Changze Song, Department of Andrology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
Song Yuan, Anesthesia and surgery center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, China, Shenzhen, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.